Biogen BIIB has outperformed the market over the past 20 years by 2.9% on an annualized basis producing an average annual return of 10.93%. Currently, Biogen has a market capitalization of $39.91 billion.
Buying $100 In BIIB: If an investor had bought $100 of BIIB stock 20 years ago, it would be worth $820.88 today based on a price of $275.00 for BIIB at the time of writing.
Biogen's Performance Over Last 20 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.